Overview

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To investigate the response of temozolomide versus prophylactic cranial radiotherapy in preventing brain metastases in completed or partial remission limited small cell lung cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Guangzhou Medical University
Treatments:
Dacarbazine
Temozolomide